LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against Kyverna Therapeutics, Inc. ("Kyverna" or "the Company") (NASDAQ:KYTX) for violations of the federal securities laws. Investors who purchased the Company’s securities pursuant and/or traceable […]
LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance Therapeutics, Inc. ("Revance" or "the Company") (NASDAQ:RVNC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder
“I wanted to create a simple accessory that would make a seat belt much more comfortable to wear,” said an inventor, fromMidlothian, Ill., “so I invented the SEAT BELT RESTRAINT. My design would also increase visibility for added safety at night.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The invention provides a new seat belt accessory for vehicles. In doing so,
Despite the economic uncertainties and post-COVID slump in recent times, MedTech companies have demonstrated strong resilience throughout 2024. The global MedTech industry market size is estimated to grow from USD 668.2 billion in 2024 to USD 694.7 billion by 2025, at a Y-o-Y increase of ~4%. Continued tech innovation, mergers, and acquisitions (M&A), commercialization of
Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative diseases, today announced several presentations by company leadership at the21st Annual Advanced Therapies Week Conference, taking place fromJanuary 20-23, 2025 at theKay Bailey Hutchinson Convention Center in Dallas, Texas.
Canada's national nuclear laboratories announces new projects with leading Canadian biopharmaceutical companies through collaborative research program CHALK RIVER, Ontario, Jan. 20, 2025 (GLOBE NEWSWIRE) — Canadian Nuclear Laboratories (CNL), Canada's premier nuclear science and technology organization, is pleased to announce that it is collaborating with two leading Canadian healthcare biotech companies – Repare Therapeutics and
Phoenix Financial Ltd., a leading Israel-based asset management, insurance, and financial group (TLV: PHOE) (“Phoenix,” the “Group,” or the “Company”), announced that former controlling shareholders Centerbridge Partners and Gallatin Point Capital completed the sale of their shares to leading international investors. Over a period of six months from July 2024 to January 2025, top-tier international
Boston, MA – O’LYN Roofing leads the roofing industry in Boston, Massachusetts, by delivering superior services to both residential and commercial clients. The company has established itself as a trusted Boston roofing contractor, known for its unwavering commitment to quality, durability, and excellent customer service. Among the services O’LYN Roofing offers are roof repairs and
Dothan, AL – Recognizing that HVAC services are essential to staying comfortable in Dothan’s ever-changing weather, Long Heating and Cooling offers reliable solutions for residential and commercial properties. The air conditioning contractor features fully licensed, professional, and dependable engineers aiming to create lasting client relationships. They supply premium air conditioning services to safeguard a building’s
The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Kyverna Therapeutics, Inc.(“Kyverna”) (NASDAQ: KYTX) on behalf of those who purchased Kyverna common stock pursuant and/or traceable to Kyverna's February 8, 2024 initial public offering (“IPO”). The lead plaintiff deadline is February 7,